SEC Comment Letter for Climb Bio, (CLYM) — Jun 4, 2026
Climb Bio, Inc.
Date: June 4, 2026 · CIK: 0001768446 · Accession: 0000000000-26-005649
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-296346
Letter
Re: Climb Bio, Inc. Registration Statement on Form S-3 Filed May 29, 2026 File No. 333-296346 Dear Aoife Brennan M.B., Ch.B.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions.
June 4, 2026
Aoife Brennan, M.B., Ch.B. President, Chief Executive Officer and Director Climb Bio, Inc. 20 William Street, Suite 145 Wellesley Hills, MA 02481
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Katharine Patterson, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 4, 2026 Aoife Brennan, M.B., Ch.B. President, Chief Executive Officer and Director Climb Bio, Inc. 20 William Street, Suite 145 Wellesley Hills, MA 02481 Re: Climb Bio, Inc. Registration Statement on Form S-3 Filed May 29, 2026 File No. 333-296346 Dear Aoife Brennan M.B., Ch.B.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Katharine Patterson, Esq. </TEXT> </DOCUMENT>